MODIFICATION TO FASTTAKE COMPACT BLOOD GLUCOSE MONITORING SYSTEM— 510(k) K001427

Substantially Equivalent

Selfcare, Inc.

FDA 510(k) clearance K001427 for MODIFICATION TO FASTTAKE COMPACT BLOOD GLUCOSE MONITORING SYSTEM, Substantially Equivalent on 2000-06-02. Applicant: Selfcare, Inc.. Device class: 2.

Clearance details

Applicant
Selfcare, Inc.
Product code
Code CGA
Device class
Class 2
Regulation
21 CFR 862.1345
Advisory panel
Clinical Chemistry
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Special
Location
Waltham, MA, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code CGA

view all

More clearances from Selfcare, Inc.

view all

Adverse events under product code CGA

product code CGA
Death
2
Malfunction
1,816
Total
1,818

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.